Phase I study of docetaxel plus S-1 combination chemotherapy for recurrent non-small cell lung cancer

S-1 is a novel oral fluorouracil prodrug that plays a role in non-small cell lung cancer (NSCLC). Docetaxel (DTX) is one of the standard agents for relapsed NSCLC. We performed a phase I study of DTX plus S-1 combination therapy as second-line treatment for NSCLC to determine the maximum tolerated d...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: FUJITAKA, KAZUNORI, HATTORI, NOBORU, SENOO, TADASHI, IWAMOTO, HIROSHI, OHSHIMO, SHINICHIRO, KANEHARA, MASASHI, ISHIKAWA, NOBUHISA, HARUTA, YOSHINORI, MURAI, HIROSHI, KOHNO, NOBUOKI
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2011
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3412446/
https://ncbi.nlm.nih.gov/pubmed/22870147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2010.218
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki